Dr Anita Bhandari’s Post

Interesting findings about how #OCTA could be used to detect changes in the retinal vasculature during and between migraine attacks. Results suggest that changes in retinal perfusion could be part of the pathophysiology of #migraine.  

Simoa® Neurology 4-Plex D (N4PD) Advantage PLUS Assay is empowering breakthroughs in neurology research 🧠 The N4PD assay enables simultaneous measurement of NfL, GFAP, UCH-L1, and brain-derived Tau (BD-Tau) in both blood and cerebrospinal fluid (CSF). These four biomarkers are crucial in understanding a wide range of neurodegenerative conditions and brain injuries.  Whether research focuses on a single neurology biomarker or explores the complex interactions of multiple markers, the Simoa® N4PD Advantage PLUS assay offers unmatched sensitivity, efficiency, and automated precision. Explore our flyer to uncover how the Simoa® N4PD Advantage PLUS is propelling research. https://bit.ly/3WMwwbk #Neurology #Biomarkers #Neurodegeneration #BDTau

developing new products and solutions is what scientists expect from a leading company and at #Quanterix this is our daily goal and our mindset for the future… stay tuned….mich more is yet to come… #SIMOA #biomarkers #neurology #oncology #development #research #IVD #diagnosticskit #neurodisease #improvment #alzheimerdisease #parkinsondisease #kits #earlydetection #diagnosis #clinicaldiagnosis #neurodegeneration #mentalhealth #mentaldisorder

Sacubitril-Valsartan in #CKD Stage-5 patients on #dialysis "This systematic review suggests that sacubitril-valsartan benefits patients with ESKD with HFrEF and HFmrEF by improving LVEF without increasing the risk of hyperkalemia, hypotension, or angioedema compared to standard care." #nephrology #nephrocardiology

🔬Live videos from our neurology labs shows some of the exciting experiments that our research teams are conducting on a daily basis.  In this experiment, InnoSer scientists have compared the neuromuscular function of healthy (WT) and diseased research subjects (C3-PMP22 research model of Charcot Marie Tooth Disease Type 1A, #CMT1A). Briefly, the hindlimbs of the research models have been stimulated and compound muscle action potentials (#CMAPs) recorded, showing significant changes in CMAP compared to healthy subjects. Calculation of latency and CMAP annotation are performed manually by our scientists to ensure accurate results. All in all, this confirms that this research model of CMT1A has significantly impaired neuromuscular function, confirming its suitability as a preclinical research model for efficacy testing of novel CMT1A targeted treatments.  👉 Read more about the C3-PMP22 model of #CMT1A here: https://lnkd.in/eSEm96Z4 👉 Interested in using the C3-PMP22 mouse model for your research? Don’t hesitate to contact us for more information here: https://lnkd.in/eHH4bmZT #SeeCMT #NavigatingCMT #NeuroscienceResearch #NeurologyCRO #NeuroscienceCRO #EuropeanNeurologyCRO #CharcotMarieToothDisease 

📢ICYMI: The deadline for submitting abstracts to the BRAIN Conference has been extended to Wednesday 9 October 2024, thanks to our partnership with SVIN - Society of Vascular and Interventional Neurology! Accepted abstracts may be published in the SVIN Journal, subject to author consent. Abstracts with the following topics can be submitted: 🧠Aneursyms 🧠Stroke 🧠ICAD 🧠Interventional Oncology 🧠DAVF 🧠AVM 🧠AI and New Technology 🧠Other Don’t miss out! Learn more and submit your abstract here: https://lnkd.in/eD3x8y4Z #BRAINConference #Neuroradiology #Neurology

This fascinating article dives into new research on the biological mechanisms causing pain in millions worldwide. https://lnkd.in/evGa9TUs A must-read for you, if interested in pain management and neuroscience. Check it out. #ScienceForAll #Neuroscience

Thrilled to share that my latest research article has been published in the esteemed Neurosurgical Review journal! Here's to continued learning, growth, and innovation in the field of neurosurgery! #Neurosurgery #Research #Publication

We are pleased to share our latest publication at #KlinikumStuttgart in collaboration with the Neurology and Neuroradiology Department of the Inselspital Bern, recently published in Neurocritical Care. The study focuses on endovascular recanalization for patients with severe sinus thrombosis, a procedure that remains significantly underrepresented in clinical practice but appears to provide a significant benefit for patient outcomes. „The main finding of this retrospective multicenter cohort study indicates a significant increase in functional independence after early versus late EVT (66.7% vs. 27.3%) in patients with severe CVST prone to a poor prognosis. We observed a nonsignificant but potentially clinically relevant reduction in mortality (16.7% vs. 36.4%) for early EVT“ Here is the link to the full Open Access article: https://lnkd.in/e4rdPfKj Special thanks to Prof. Hans Henkes for his continuous support and Philipp Bücke for his excellent work on this topic. #EVT #CVST #mechanical #thrombectomy #neurointervention #neurology Philipp Bücke Hans Henkes Alexandru Cimpoca Johannes Kaesmacher

Check out the great work on CLDN1 and organ fibrosis presented by Prof. Pierre-Louis Tharaux's team and Prof. Wim Wuyts's team at the ERA and ATS conferences. Their collaborative research is paving the way for future treatment strategies. #FibrosisResearch #Innovation #ERA2024 #ATS2024"